Search

everythinglearnresearchcommunity

for

Search:↓

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Testosterone supplements can increase muscle mass and strength in older men with low levels, but long-term effects and risks need more research.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Finasteride didn't significantly improve ICPPS symptoms, more research needed.

Researchers found 63 genes linked to male-pattern baldness, which could help in understanding its biology and developing new treatments.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Antiandrogens may help treat conditions like excessive hair growth, prostate tumors, male baldness, and acne by blocking male hormone effects.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Tamoxifen effectively treats gynecomastia without causing impotence.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Older men with severe symptoms and larger prostates should focus on prevention, using finasteride and alpha-blockers to manage acute urinary retention.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Testosterone can build muscle and bone without enlarging the prostate when a specific enzyme is blocked.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Some plant-derived compounds may help with hormonal conditions, but more research is needed to confirm their effectiveness.

Finasteride reduces male rat fertility by causing issues with copulatory plug formation.